Skip to content
10-Q

Quarterly Report

QLY BIOTECH GROUP CORP.

0001477932-21-009135

← back to feed
Filed
Dec 13, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · Dec 9, 2021 3.9M sh
Cash And Equivalents Q1 2022 · Nov 30, 2021 $1.16K
Cash And Equivalents Q1 2022 · Aug 31, 2021 $5.17K
Cash And Equivalents Q1 2022 · Nov 30, 2020 $23.52K
Cash And Equivalents Q1 2022 · Aug 31, 2020 $27.63K
Current Liabilities Q1 2022 · Nov 30, 2021 $12.9K
Current Liabilities Q1 2022 · Aug 31, 2021 $13.12K
Total Liabilities Q1 2022 · Nov 30, 2021 $12.9K
Total Liabilities Q1 2022 · Aug 31, 2021 $13.12K
Current Assets Q1 2022 · Nov 30, 2021 $1.16K
Current Assets Q1 2022 · Aug 31, 2021 $5.17K
Total Assets Q1 2022 · Nov 30, 2021 $2.72K
Total Assets Q1 2022 · Aug 31, 2021 $7.16K
Operating Cash Flow Q1 2022 · Nov 30, 2020 −$4.11K
Stockholders Equity restated Q1 2022 · Nov 30, 2020 −$19K
Stockholders Equity Q1 2022 · Aug 31, 2020 $23.54K
Sga Expense Q1 2022 · Nov 30, 2020 $4.54K
Net Income Q1 2022 · Nov 30, 2020 −$4.54K
Cost Of Revenue Q1 2022 · Nov 30, 2020 $0
Revenue Q1 2022 · Nov 30, 2020 $0